Different streptomycin-resistant strains of Escherichia coli, including an R100 plasmid-carrying strain of E. coli W3110, the ribosomally resistant mutant SM10, and the spontaneous revertant from dependence to independence d1023, exhibited poor accumulation capacity for aminoglycoside antibiotics. This was due to a faiMlre of these mutants to induce the general polyamine transport system that is utilized by streptomycin to enter the cell. It is shown that the aminoglycoside kanamycin, which is effective on these streptomycin-resistant strains, was capable of inducing the uptake of streptomycin, thus giving rise to streptomycin accumulation up to wild-type levels. Plasmid-determined resistance, which has been speculated to be the result of a blockage of the uptake system by modified antibiotic molecules, cannot be overcome by the induction of streptomycin transport. Increase in permeability of the antibiotic does not affect the susceptibility of the bacteria. It is shown that all of the antibiotic taken up was enzymatically modified. R-plasmid-conferred resistance to aminoglycosides is therefore explained by the inactivation of the antibiotic entering the bacterial cell.
Streptomycin uptake by susceptible strains of Escherichia coli displays the peculiar phenomenon of autoinduction. During prolonged incubation in the presence of the antibiotic the cells induce a general polyamine transport system that can also be utilized by streptomycin (10) . The uptake of the antibiotic is thereby greatly stimulated. Enhancement of uptake has been shown to be absent in both ribosomally altered (2) and R-plasmid-carrying resistant strains (4) .
In a recent report it was demonstrated that induction of streptomycin uptake can be achieved not only by streptomycin itself but also by a number of other aminoglycoside antibiotics (10) . In this communication induction of streptomycin uptake in different classes of streptomycin-resistant strains of E. coli is described.
Two types of ribosomally streptomycin-resistant mutants were investigated: the streptomycin-resistant mutant SM10, which is altered in the 30S ribosomal protein S 12 (8) , and the spontaneous revertant from dependence to independence d1023, which has been shown to result from an additional change in a second protein, namely the S 5 (9) (the corresponding dependent mutant will be described elsewhere). Streptomycin resistance caused by an R-factor was studied by using the R100 plasmid, which codes for an aminoglycoside-3'-adenylyltransferase.
Plasmid-determined resistance of bacteria to aminoglycoside antibiotics has been explained by the combined effects of the inactivation of a small fraction of the drug and the resulting blockage of the uptake of the residual unmodified molecules by the inactivated antibiotic (6, 7) . Hence, active antibiotic would be prevented from gaining access to a vulnerable target. Recently, resistance to the drug which is determined by a plasmid has been proposed to be the result of two concomitant events; these are, first, the rate of inactivation and, second, the rate of transport of the drug (3). The achievement of induction of streptomycin uptake in resistant strains was expected to give further insights into the molecular events causing streptomycin resistance.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All bacterial strains used in this study were ,uCi/mnl. Shaking was continued, and samples (1 ml in streptomycin experiments and 200 ptl in polyamine uptake experiments) were periodically withdrawn and rapidly vacuum filtered through cellulose nitrate membrane filters (pore size, 0.4 pm; Sartorius Membranfilter GmbH, Gottingen, Germany). The cells retained on the filter were rinsed three times with 3 ml of a 0.1 M LiCl solution. The filters were dried at 600C, 5 ml of toluene-based scintillation fluid was added, and the radioactivity was determined in a liquid scintillation counter (model Mark II; Nuclear-Chicago Corp., Des Plaines, Ill.). The results were corrected for changes in the absorbance of the culture during the uptake experiment. The absorbance was calculated by the linear interpolation of measurements taken at the beginning and at the end of the incubation.
Extraction of streptomycin from the bacterial cell. The wild-type E. coli W3110 and its corresponding derivative carrying the plasmid were grown in complex medium at 37°C until an absorbance of 0.25 was reached. Samples (5 ml) of the cultures were incubated in the presence of 5 ,ug of kanamycin per ml at 370C for 20 min. Uptake was initiated by the addi-
give a final concentration of 5 ,ug/ml. The samples were spun down, washed once with saline, suspended in 1 ml of saline, and centrifuged in an Eppendorf microcentrifuge. The pellet was suspended in and extracted with 5% trichloroacetic acid at room temperature for 30 min with occasional shaking. After centrifugation a sample of the supernatant was spotted onto electrophoresis strips.
Thin-layer electrophoresis. Electrophoresis of modified streptomycin was performed on Cellogel (Serva, Heidelberg, Germany) cellulose polyacetate strips (2.5 by 17 cm; 0.25 to 0.3 mm thick) in a water-pyridine-glacial acetic acid (400:3:10, vol/vol/ vol) buffer, pH 3.9, for 2.5 h at 1 mA per strip (1). The dried strip was cut into segments 0.5 cm long, and the radioactivity was determined as described above. 
RESULTS
Streptomycin uptake in E. coli W3110 harboring the R100 plasmid, in the streptomycinresistant mutant SM10, and in the streptomycinindependent mutant d1023 was shown to be very ANTIMICROB. AGENTS CHEMOTHER.
poor (Fig. 1) . The typical enhancement in accumulation rate during prolonged uptake as seen in susceptible strains ( Fig. 1 ) was missing. Preincubation of the cells in the presence of unlabeled streptomycin did not stimulate the uptake of labeled streptomycin. This is in contrast to the finding with susceptible strains of E. coli ( Fig.  1) (10) .
Resistance to aminoglycoside antibiotics is frequently restricted to certain compounds. The R100 plasmid, for example, confers resistance only to streptomycin due to the plasmid-coded aminoglycoside -3'-adenylyltransferase. Resistant mutants with altered ribosomes become resistant to one specific aminoglycoside, depending on the ribosomal protein affected by the mutation. The three different streptomycin-resistant strains of E. coli which were chosen to investigate the inducibility of streptomycin uptake are all sensitive to kanamycin. Preincubation of the mutant cells in the presence of this aminoglycoside dramatically increased the uptake of streptomycin (Fig. 1) . The uptake of the polyamine spermidine was also stimulated in the presence of kanamycin (Fig. 1) .
Induction of streptomycin and spermidine uptake was fully expressed after preincubation for 20 min in the presence of kanamycin. As shown in Fig. 2 , the degree of induction of uptake did not increase in proportion to the concentration of kanamycin but rather depended on a critical value of kanamycin concentration, which under the given conditions was about 2.5 ,ug/ml for E. coli R100.
The uptake experiments showed that addition of kanamycin to the culture caused accumulation of streptomycin inside the cell at a concentration comparable to that in the susceptible wild-type strain (Fig. 1) . The critical question remained: Did the accumulated antibiotic kill the bacteria?
Determinations of the minimum inhibitory concentrations for the R100 plasmid-carrying E. coli strain W3110 yielded the following data: minimal inhibitory concentration for streptomycin alone, 156 ,g/ml; miniimal inhibitory concentration for kanamycin alone, 0.25 ug/ml; and miniimal inhibitory concentrations for the combination of drugs, 62.5 ,ug of streptomycin per ml and 0.078 ,tg of kanamycin per ml. These results do not differ substantially from the values obtained with the susceptible strain. It may, therefore, be concluded that the high concentration of streptomycin inside the cell is somehow hindered in its lethal action.
It was very possible that streptomycin had been inactivated by the plasmid-coded modifying enzyme. To test this hypothesis, the accumulated streptomycin of a susceptible strain and ]spermidine were determined in the wild-type E. coli W3110 and its corresponding derivative carrying the R100 plasmid, in the streptomycin-resistant mutant SM1O of E. coli K-12, and in the revertant from streptomycin dependence to independence dlO23 of E. coli K-12. Uptake was determined with cells which had not been pretreated (0), which had been preincubated in the presence of 5 pg of streptomycin per ml ---@), and which had been preincubated in the presence of 5 .g of kanamycin per ml -@). a plasmid-carrying strain was extracted with trichloroacetic acid and characterized electrophoretically. To get a high accumulation of streptomycin, both strains were first induced for uptake by preincubation for 20 min at 37°C with 5 ,Ag of kanamycin per ml. Both strains accumulated similar amounts of dihydrostreptomycin (433 nmol/g of cells for the wild-type and 546 nmol/g of cells for the plasmid-carrying strain). The accumulated antibiotic was extracted, with a comparable yield of about 75% from both strains (71% for the wild type and 76% for the plasmid-carrying strain). As can be seen in Fig. 3 , the reisolated streptomycin from the wild-type cells seemed to be unchanged, whereas more than 90% of the extracted streptomycin from the resistant strain showed a change in its electrophoretic behavior, indicating a modification of the streptomycin. As would be expected for an adenyl derivative of streptomycin, the inactivated product moved less far to the cathode than did the unchanged streptomycin in the low-pH electrophoresis system used to separate the products (11) . DISCUSSION Uptake of steptomycin which is induced by streptomycin in susceptible' strains of E. coli cannot be induced in streptomycin-resistant strains, irrespective of whether resistance is me-ANTIMICROB. AGENTS CHEMOTHER. diated by inactivating enzymes or by alteration of ribosomal proteins, causing either resistance or independence. The results presented in this communication, however, demonstrate that certain other aminoglycoside antibiotics can induce streptomycin uptake also in resistant strains.
This induces not only the uptake of streptomycin but also the uptake of the polyamine spermidine. This is consistent with the recent finding that enhancement of streptomycin uptake represents the induction of a general polyamine transport system (10) . The capacity of a drug for inducing streptomycin accumulation must meet two requirements. The drug has to be effective on the strain, and, since spectinomycin and kasugamycin are ineffective in inducing uptake (10) , the drug has to interact with the ribosomal proteins in a specific way. Thus, a method is described which overcomes the low permeability of streptomycin inherent in certain resistant strains.
This finding is, of course, of no consequence with streptomycin-resistant mutants altered in ribosomal proteins. However, since it has been argued that plasmid-determined resistance may be due to a block of the uptake system of the antibiotic rather than to inactivation of the drug (6, 7), one would have anticipated a marked increase in the susceptibility of the strain to streptomycin. This report, however, shows that stimulation of streptomycin uptake by the induction of an additional transport system in Rfactor-carrying strains does not confer susceptibility to streptomycin. Thus, inactivation of the antibiotic rather than inhibition of its uptake is of paramount importance in determining resistance.
It seems reasonable to assume that streptomycin becomes inactivated only after having passed the first permeability barrier, the outer membrane, of a gram-negative bacterium. When it is just entering the second barrier, the cytoplasmic membrane, it encounters the modifying enzyme, which resides somewhere within the cell envelope (6) . The antibiotic may then become trapped in the cell because it is chemically modified and can no longer escape by its route of entry. Such a mechanism would explain why the presence of streptomycin-inactivating enzymes in resistant strains does not result in inactivation of a distinct fraction of the drug in the medium (6) .
The process of modification of streptomycin apparently occurs with at least the same rate as uptake. Only inactivated molecules accumulate inside the cell, and, therefore, no induction of uptake occurs. A similar model has been proposed before by Bryan and Van Den Elzen (3). 
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The results presented here reveal that the rate of inactivation can keep pace with the rate of uptake even under conditions of fully induced uptake of streptomycin. One exception to this situation has been reported recently for Staphylococcus aureus (5) . A novel amikacin-modifying enzyme was detected in clinical isolates, which does not confer amikacin resistance to the strains. It could very well be that in this case the rate of inactivation of the drug is lower than the rate of uptake of amikacin, resulting in an accumulation of unmodified drug in sufficiently high concentration in the cell.
Bryan and Van Den Elzen recently pointed out that bacteria modifying one aminoglycoside but not another are still susceptible to the second in the presence of the first (3). This is confirmed in the present study, which in addition demonstrates that even enhancement of uptake can be achieved under such conditions. Modification of one aminoglycoside does not influence the uptake of another aminoglycoside which is not a substrate for the inactivating enzyme. Either each aminoglycoside has its own entry system, which seems very unlikely, or there is no general block of aminoglycoside uptake by the inactivation of one aminoglycoside antibiotic, as has been proposed (6, 7). The latter seems to be the case, since the failure of streptomycin-resistant strains, including ribosomally altered strains, to accumulate high amounts of the drug is easily explained by the absence of the autoinduction phenomenon in these strains. Induction of the general polyamine transport system depends on an unmodified active antibiotic, and it has been shown that this does not occur in strains with ribosomally based resistance to the antibiotic.
In sunmary, it can be concluded that streptomycin-resistant bacteria display low permneability to the antibiotic because they are unable to induce an additional transport system to be utilized by the antibiotic; either the streptomycin is enzymatically inactivated or the antibiotic cannot effectively interact with altered ribosomes.
